Related Experiment Video
Updated: Feb 11, 2026

The Dimethylnitrosamine Induced Liver Fibrosis Model in the Rat
Published on: June 17, 2016
Ursolic acid ameliorates CCl4-induced liver fibrosis through the NOXs/ROS pathway
Dakai Gan1, Wang Zhang2, Chenkai Huang2
1Department One of Liver Disease, The Ninth Hospital of Nanchang, Nanchang, People's Republic of China.
Abstract:
Liver fibrosis is a reversible wound-healing response that occurs after liver injury. NADPH oxidases (NOXs) and reactive oxygen species (ROS) which are expressed in hepatocytes (HCs), hepatic stellate cells (HSCs), and Kupffer cells (KCs) play an important role in the development of hepatic fibrosis. In in vitro studies, we had shown that ursolic acid (UA) could reverse liver fibrosis by inhibiting the activation of NOX-mediated fibrotic signaling networks in HSCs. In this study, we verified that UA could alleviate CCl4-induced liver fibrosis by reducing the expression of NOXs/ROS in HCs, HSCs, KCs. Meanwhile, the phagocytic index α and clearance index K which represent phagocytosis of KCs were unchanged. Together, all our data demonstrated that UA induced the proliferation of HCs, promoted apoptosis in HSCs, and prevented activation of KCs in vivo by reducing the expression of NOXs/ROS in HCs, HSCs, KCs. Besides, UA had no effect on the host defense function.
Insights
Ursolic acid (UA) reverses liver fibrosis by reducing NADPH oxidases (NOXs) and reactive oxygen species (ROS) in liver cells. This treatment promotes hepatocyte proliferation and hepatic stellate cell apoptosis without impairing host defense.
Area of Science:
- Hepatology
- Cell Biology
- Biochemistry
Background:
- Liver fibrosis is a dynamic wound-healing process following liver injury.
- NADPH oxidases (NOXs) and reactive oxygen species (ROS) are implicated in hepatic fibrosis development.
- Ursolic acid (UA) demonstrated antifibrotic effects in vitro by inhibiting NOX-mediated signaling in hepatic stellate cells (HSCs).
Purpose of the Study:
- To investigate the in vivo efficacy of ursolic acid (UA) in alleviating carbon tetrachloride (CCl4)-induced liver fibrosis.
- To elucidate the mechanisms underlying UA's antifibrotic effects, focusing on NOX/ROS pathways in hepatocytes (HCs), HSCs, and Kupffer cells (KCs).
Main Methods:
- CCl4-induced liver fibrosis model in vivo.
- Assessment of UA's effects on NOX and ROS expression in HCs, HSCs, and KCs.
- Evaluation of KC phagocytic activity (indices α and K).
- Analysis of UA's impact on HC proliferation, HSC apoptosis, and KC activation.
Main Results:
- UA alleviated CCl4-induced liver fibrosis by decreasing NOX and ROS expression across HCs, HSCs, and KCs.
- UA treatment promoted HC proliferation and induced apoptosis in HSCs.
- KC activation was prevented by UA, while phagocytic function remained unaffected.
- UA did not compromise the host defense function.
Conclusions:
- Ursolic acid (UA) effectively reverses liver fibrosis in vivo.
- UA exerts its antifibrotic effects by modulating NOX/ROS pathways, promoting hepatocyte health, and inducing apoptosis in fibrogenic cells.
- UA represents a potential therapeutic agent for liver fibrosis without compromising immune function.
Related Concept Videos
Amino Acid Biosynthetic Pathways
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
The Citric Acid Cycle
Cystic Fibrosis: Management
Sinus disease and chronic...
Other Glycolytic Pathways

